Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations

Qi Liu , Senyan Wang , Jing Fu , Yao Chen , Jing Xu , Wenjuan Wei , Hao Song , Xiaofang Zhao , Hongyang Wang

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (8) : e1812

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (8) : e1812 DOI: 10.1002/ctm2.1812
REVIEW

Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations

Author information +
History +
PDF

Abstract

The liver possesses a distinctive capacity for regeneration within the human body. Under normal circumstances, liver cells replicate themselves to maintain liver function. Compensatory replication of healthy hepatocytes is sufficient for the regeneration after acute liver injuries. In the late stage of chronic liver damage, a large number of hepatocytes die and hepatocyte replication is blocked. Liver regeneration has more complex mechanisms, such as the transdifferentiation between cell types or hepatic progenitor cells mediated. Dysregulation of liver regeneration causes severe chronic liver disease. Gaining a more comprehensive understanding of liver regeneration mechanisms would facilitate the advancement of efficient therapeutic approaches. This review provides an overview of the signalling pathways linked to different aspects of liver regeneration in various liver diseases. Moreover, new knowledge on cellular interactions during the regenerative process is also presented. Finally, this paper explores the potential applications of new technologies, such as nanotechnology, stem cell transplantation and organoids, in liver regeneration after injury, offering fresh perspectives on treating liver disease.

Keywords

interventions / liver injury model / liver regeneration / signalling pathway

Cite this article

Download citation ▾
Qi Liu, Senyan Wang, Jing Fu, Yao Chen, Jing Xu, Wenjuan Wei, Hao Song, Xiaofang Zhao, Hongyang Wang. Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations. Clinical and Translational Medicine, 2024, 14(8): e1812 DOI:10.1002/ctm2.1812

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

138

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/